Stock·NYSE·Consumer Cyclical
DICK'S Sporting Goods, Inc. (DKS)
- Market cap
- $14.24B
- P/E
- 15.71
- Dividend yield
- 3.44%
- Street target
- $170.00median of 27 analysts
- 52-week range
- $120.15 $244.38
DKS stock forecast today
Where DKS stands today, and what CleaRank Financial AI makes of it.
DKS at a glance
DICK'S Sporting Goods, Inc. (DKS): Buy, 62/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($141.06 and $194.09).
- Earnings DKS beat estimates in 6 of its last 8 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $24.4M and bought $6.1M over the last 18 months.
- Valuation P/E of 15.7 against 20.8 for the Consumer Cyclical sector: a discount to peers (-24%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates DICK'S Sporting Goods, Inc. (DKS) Buy, with a model score of 62/100.
Valuation lifts the score most: the P/E of 15.71 is 24.5% below the sector median (a discount to peers) and the P/S of 0.67 is 64.7% below the sector median. The trend holds it back most: the price is 25.56% below its 200-day average, and the 50-day average is 27.32% below the 200-day. The 50-day average stands at $141.06 and the 200-day at $194.09. Over the past year the price fell 35.89%.
Only on CleaRank
Figures we compute ourselves from DKS's own price, earnings and insider-filing history. Tap one to see it in context.
DKS stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $144.48 is 2.4% above the 50-day simple moving average of $141.06.Price above its 200-day average ›
The price is 25.6% below the 200-day simple moving average of $194.09.50-day average above the 200-day ›
The 50-day average ($141.06) is 27.3% below the 200-day average ($194.09), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 20% of its 52-week range, between $120.15 and $244.38.
DKS share price
Pick a period: each tab shows how far DKS has moved over it, to the last close.
Today's trading
Where DKS sits inside today's range and its 52-week range.
DKS fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 15.71 is 24.5% below the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 0.67 is 64.5% below the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $838.8M on revenue of $21.1B, a net margin of 4.0%.Beat estimates in most recent reports ›
DKS beat the EPS estimate in 6 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 3.44%, or $4.96 a share a year.
Key statistics
The headline figures for DKS.
As of October 26, 2026, DKS trades at $144.48, with a market value of $14.24B, a P/E ratio of 15.71 and a dividend yield of 3.44%.
What the numbers say
CleaRank Financial AI's reading of DKS's valuation, growth and risks.
DICK'S Sporting Goods, Inc. (DKS)'s trailing P/E of 15.71 compares with a Consumer Cyclical median of 20.8, 24.5% below it, which the peer comparison on this page rates as a discount to peers. DKS has a market capitalisation of $14.2B.
DKS is growing faster than its sector: revenue rose 53.20% in the latest quarter, year on year, while the sector median is 7.2%. Its net margin stands at 3.97% and its operating margin at 7.67%. Return on equity is 18.48%, which is above the sector median of 12.4%. On the balance sheet, debt-to-equity is 1.39, and the trailing dividend yield is 3.44%, equal to $4.96 a share a year.
DKS reported on August 25, 2026 and came in under expectations, with EPS of $3.53 against an estimate of $3.76, a miss of 6.12%. Investors pushed the shares the other way: the stock climbed 4.30% in the next session.
Across its last 8 reports, DKS has beaten the EPS estimate in 6 cases, yet a beat has not reliably lifted the shares: the stock dropped the next session after 3 of those beats. For this fiscal year, analysts average an EPS estimate of $11.43, a drop of 13.4%. Their average for next year is $13.05, which implies growth of 14.2%.
DKS typically moves about 2.30% in a day, and its beta against the S&P 500 is 1.10. The price is 40.88% below the $244.38 high reached over the past 52 weeks. Over the last 18 months insiders sold $24.4M of stock and bought $6.1M. Insider sales are often planned ahead or made to cover taxes on vesting shares, so they tell less than open-market purchases do.
DKS against the Consumer Cyclical sector
How DKS compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: DKS trades at a notable discount to sector peers (-24%), which may indicate undervaluation or specific company headwinds.
Return vs SPY: Since May 14, 2025, DKS has lost 31.1% against a gain of 30.3% for SPY.
Performance against SPY
DKS and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much DKS sells, and how much of it becomes profit.
Revenue growth: Revenue grew 28.1% in FY2026 to $17.2B, from $13.4B a year earlier.
Profit margin: The net margin was 4.9% in FY2026, down from 8.7% the year before.
Profitable: DKS earned $849M in FY2026.
Earnings reality check
Did DKS beat what analysts expected, and how did the stock react?
Earnings record: DKS beat the analyst estimate in 6 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 25, 2026after close | $3.76 | $3.53 | -6.12% | +4.30% | +6.95% |
| May 27, 2026after close | $2.91 | $2.90 | -0.34% | +3.24% | +2.26% |
| Mar 12, 2026after close | $2.95 | $3.45 | +16.95% | -2.75% | -2.31% |
| Nov 25, 2025after close | $2.71 | $2.78 | +2.58% | +0.33% | +10.26% |
| Aug 28, 2025after close | $4.30 | $4.38 | +1.86% | -1.06% | +2.86% |
| May 15, 2025after close | $3.21 | $3.37 | +4.98% | +2.78% | -3.71% |
| Mar 11, 2025after close | $3.51 | $3.62 | +3.13% | -1.91% | -2.87% |
| Nov 26, 2024after close | $2.69 | $2.75 | +2.23% | +0.68% | -0.29% |
As of October 26, 2026, DKS has beaten the analyst EPS estimate in 6 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on August 25, 2026, came in 6.12% below the estimate and the stock moved +4.30% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
DKS AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 55.1, in neutral territory.RSI above 50 ›
An RSI of 55.1 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of DKS
The score, the reasoning behind it, and what could move the price next.
DKS is giving a mixed trend reading. The stock, at $144.48, is 2.42% above its 50-day average of $141.06, yet 25.56% below its 200-day average of $194.09. Sitting near the floor of its 52-week range, it is 20.25% above the $120.15 low and 40.88% below the $244.38 high.
Recent gains are set against a weaker record over longer periods. The price is up 5.90% over the past month, but it is down 29.73% over three months and down 35.89% over the past year. The 14-day RSI sits at 55.1, in the neutral zone, and the MACD line is positive.
New analyst coverage ›
Wolfe Research started coverage at Outperform on October 22, 2026.
Source: Analyst action, Wolfe Research, October 22, 2026
Analyst downgrade ›
Baird downgraded it to Neutral from Outperform on September 14, 2026.
Source: Analyst action, Baird, September 14, 2026
Earnings miss, but the stock rose ›
The August 25, 2026 report missed the EPS estimate by 6.12%, and the share price rose 4.30% in the first session after it.
Source: Earnings report, August 25, 2026
- The two closest levels to watch are the 200-day SMA at $194.09, above the price, and the 50-day SMA at $141.06, below it.
- The 14-day RSI reads 55.1, in the neutral zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- Following the August 25, 2026 report, the share price climbed 4.30% in the first session. Over the last 8 reports, DKS has beaten estimates 6 times.
The trend is mixed: DKS is above its 50-day average at $141.06 but below its 200-day average at $194.09. A close above the 200-day would turn both signals up, and a close below the 50-day would turn both down. The nearest levels are the 50-day SMA at $141.06 below and the 200-day SMA at $194.09 above.
Technical indicators
Momentum and trend for DKS, from its daily closes.
As of October 26, 2026, with DKS at $144.48, its 14-day RSI is 55.1 (neutral territory), its 50-day simple moving average is $141.06 and its 200-day is $194.09.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What DKS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, DKS's 1-year correlation of daily returns is +0.39 with S&P 500 (SPY), +0.33 with Nasdaq 100 (QQQ), +0.09 with Bitcoin (BTC) and +0.02 with gold (XAU).
DKS price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
13 of 27 analysts rate it a buy or strong buy, 12 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $170.00 is 17.7% above the price.More buy ratings than three months ago ›
13 of 27 rate it a buy now, against 15 of 26 three months ago.
DKS Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 22, 2026 | Wolfe Research | Initiates | Outperform |
| Oct 1, 2026 | Truist Securities | Maintains | Hold |
| Sep 14, 2026 | Baird | Downgrade | Neutral |
| Sep 9, 2026 | BMO Capital | Initiates | Underperform |
| Aug 27, 2026 | Citigroup | Maintains | Buy |
| Aug 27, 2026 | UBS | Maintains | Buy |
As of October 26, 2026, 27 Wall Street analysts cover DKS: 13 rate it a buy or strong buy, 12 a hold and 2 a sell or strong sell. Their 12-month price targets range from $99.00 to $205.00. The median DKS price target is $170.00, 17.7% above the price of $144.48.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
DKS trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
DKS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from DKS's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much DKS tends to move, against the market and on its own.
DKS price history and drawdowns
DKS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.30% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 66.8%, from December 2016 to March 2020, regained by September 2020.Most 1-year holds ended higher ›
70% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $33,626, against $42,015 in the S&P 500 (SPY).
DKS Drawdowns & Recovery
As of October 26, 2026, DKS's worst peak-to-trough fall over the last 10 years with dividends reinvested was -66.8% (December 2016 to March 2020); it regained that peak by September 2020, 6 months after the low, and 70% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into DKS in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: DKS trailed the S&P 500 over this period: $33,626 against $42,015.
A $10,000 investment in DKS in October 2016 would be worth about $33,626 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to DKS, and which have not.
Strongest month, January: an average of +7.80%, up in 9 of 10 years.
Weakest month, May: an average of -6.20%, up in 3 of 10 years.
This month, October: has averaged -2.44%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, DKS's strongest calendar month has been January (average +7.80%, up in 9 of 10 years) and its weakest May (average -6.20%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
DKS stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in DKS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in DKS today could grow to about $13,513 by 2030 in the base case, with a 90th-percentile outcome near $45,376 and a 10th-percentile outcome around $4,024. The simulation models price only; at today's 3.44% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
DKS Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $195 for DKS by 2030 in the base case, from $144 today (1.4x over 4 years). The 10th-percentile path ends near $58.14. These are outcomes of a Monte Carlo simulation run on DKS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $85.01 | $156 | $285 | |
| 2028 | $71.32 | $168 | $396 | |
| 2029 | $63.43 | $181 | $517 | |
| 2030 | $58.14 | $195 | $656 |
Method: a lognormal simulation of DKS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
DKS insider trading
What the people running the company have bought and sold.
DKS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $6.1M on the open market and sold $24.4M.
As of October 26, 2026, DKS insiders reported 8 open-market sales worth $24.4M and 9 open-market purchases worth $6.1M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Matthew Barnes
Officer
|
Buy | 3.7K | $499.9K |
| Sep 23, 2026 | Larry Fitzgerald Jr.
Director
|
Buy | 1.9K | $244.9K |
| Sep 22, 2026 | Navdeep Gupta
Chief Financial Officer
|
Buy | 7.7K | $1,000.0K |
| Sep 1, 2026 | William J Colombo
Director
|
Buy | 913 | $121.6K |
| Aug 27, 2026 | Mark J Barrenechea
Director
|
Buy | 17.0K | $2.2M |
| Aug 27, 2026 | William J Colombo
Director
|
Buy | 6.1K | $785.5K |
| Aug 26, 2026 | Robert W. Eddy
Director
|
Buy | 4.0K | $514.8K |
| Aug 26, 2026 | Sandeep Lakhmi Mathrani
Director
|
Buy | 1.6K | $199.8K |
| Jun 24, 2026 | Edward W Stack
Officer, Director and Beneficial Owner
|
Option | 958.5K | $10.8M |
| Jun 10, 2026 | Mark J Barrenechea
Director
|
Grant | 838 | - |
| Jun 10, 2026 | Emanuel Chirico
Director
|
Grant | 838 | - |
| Jun 10, 2026 | William J Colombo
Director
|
Grant | 838 | - |
| Jun 10, 2026 | Robert W. Eddy
Director
|
Grant | 838 | - |
| Jun 10, 2026 | Anne Fink
Director
|
Grant | 838 | - |
| Jun 10, 2026 | Larry Fitzgerald Jr.
Director
|
Grant | 838 | - |
| Jun 10, 2026 | Sandeep Lakhmi Mathrani
Director
|
Grant | 838 | - |
| Jun 10, 2026 | Desiree Ann Ralls-Morrison
Director
|
Grant | 838 | - |
| Jun 10, 2026 | Lawrence J Schorr
Director
|
Grant | 838 | - |
| May 28, 2026 | Lauren R Hobart
Chief Executive Officer
|
Sell | 20.1K | $4.6M |
| May 28, 2026 | Lauren R Hobart
Chief Executive Officer
|
Option | 20.1K | $227.1K |
| Apr 20, 2026 | Julie Lodge-Jarrett
Officer
|
Grant | 150 | - |
| Apr 17, 2026 | Julie Lodge-Jarrett
Officer
|
Sell | 4.1K | $925.5K |
| Apr 17, 2026 | Julie Lodge-Jarrett
Officer
|
Option | 4.1K | $53.1K |
| Apr 2, 2026 | Elizabeth H. Baran
General Counsel
|
Grant | 1.6K | - |
| Apr 2, 2026 | Matthew Barnes
Officer
|
Grant | 3.9K | - |
| Apr 2, 2026 | Ann Freeman
Officer
|
Grant | 3.9K | - |
| Apr 2, 2026 | Navdeep Gupta
Chief Financial Officer
|
Grant | 4.9K | - |
| Apr 2, 2026 | Lauren R Hobart
Chief Executive Officer
|
Grant | 20.9K | - |
| Apr 2, 2026 | Julie Lodge-Jarrett
Officer
|
Grant | 5.9K | - |
| Apr 2, 2026 | Vladimir Rak
Chief Technology Officer
|
Grant | 3.3K | - |
| Apr 2, 2026 | Raymond A. Sliva Jr
Officer
|
Grant | 3.3K | - |
| Apr 2, 2026 | Edward W Stack
Officer, Director and Beneficial Owner
|
Grant | 45.6K | - |
| Apr 2, 2026 | Michael E. Stack
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.6K | - |
| Mar 24, 2026 | Elizabeth H. Baran
General Counsel
|
Grant | 1.4K | - |
| Mar 24, 2026 | Navdeep Gupta
Chief Financial Officer
|
Grant | 4.3K | - |
| Mar 24, 2026 | Lauren R Hobart
Chief Executive Officer
|
Grant | 21.5K | - |
| Mar 24, 2026 | Julie Lodge-Jarrett
Officer
|
Grant | 2.9K | - |
| Mar 24, 2026 | Vladimir Rak
Chief Technology Officer
|
Grant | 3.6K | - |
| Mar 24, 2026 | Raymond A. Sliva Jr
Officer
|
Grant | 4.3K | - |
| Mar 24, 2026 | Edward W Stack
Officer, Director and Beneficial Owner
|
Grant | 43.1K | - |
| Mar 24, 2026 | Michael E. Stack
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.4K | - |
| Dec 16, 2025 | Navdeep Gupta
Chief Financial Officer
|
Grant | 950 | - |
| Dec 3, 2025 | Matthew Barnes
Officer
|
Grant | 4.4K | - |
| Nov 26, 2025 | Emanuel Chirico
Director
|
Grant | 9.6K | - |
| Oct 14, 2025 | Lawrence J Schorr
Director
|
Grant | 1.5K | - |
| Oct 3, 2025 | Ann Freeman
Officer
|
Grant | 4.3K | - |
| Sep 29, 2025 | Lauren R Hobart
Chief Executive Officer
|
Sell | 20.1K | $4.4M |
| Sep 29, 2025 | Lauren R Hobart
Chief Executive Officer
|
Option | 20.1K | $227.1K |
| Sep 4, 2025 | Elizabeth H. Baran
General Counsel
|
Grant | 10 | - |
| Aug 13, 2025 | Navdeep Gupta
Chief Financial Officer
|
Sell | 13.3K | $3.0M |
| Jul 10, 2025 | Navdeep Gupta
Chief Financial Officer
|
Sell | 9.3K | $2.0M |
| Jul 2, 2025 | Elizabeth H. Baran
General Counsel
|
Sell | 1.8K | $374.5K |
| Jul 2, 2025 | Elizabeth H. Baran
General Counsel
|
Option | 500 | $5.7K |
| Jun 27, 2025 | Lauren R Hobart
Chief Executive Officer
|
Sell | 40.2K | $8.2M |
| Jun 27, 2025 | Julie Lodge-Jarrett
Officer
|
Sell | 4.6K | $871.0K |
| Jun 27, 2025 | Lauren R Hobart
Chief Executive Officer
|
Option | 40.2K | $454.3K |
| Jun 26, 2025 | Robert W. Eddy
Director
|
Buy | 2.6K | $501.1K |
| Jun 11, 2025 | Mark J Barrenechea
Director
|
Grant | 975 | - |
| Jun 11, 2025 | Emanuel Chirico
Director
|
Grant | 975 | - |
| Jun 11, 2025 | William J Colombo
Director
|
Grant | 975 | - |
| Jun 11, 2025 | Robert W. Eddy
Director
|
Grant | 975 | - |
| Jun 11, 2025 | Anne Fink
Director
|
Grant | 975 | - |
| Jun 11, 2025 | Larry Fitzgerald Jr.
Director
|
Grant | 975 | - |
| Jun 11, 2025 | Sandeep Lakhmi Mathrani
Director
|
Grant | 975 | - |
| Jun 11, 2025 | Desiree Ann Ralls-Morrison
Director
|
Grant | 975 | - |
| Jun 11, 2025 | Lawrence J Schorr
Director
|
Grant | 975 | - |
| Jun 11, 2025 | Larry D Stone
Director
|
Grant | 975 | - |
Source: TwelveData, from SEC Form 4 filings
DKS stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.